Effects of α-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation "bath salts," on intracranial self-stimulation thresholds in rats

International Journal of Neuropsychopharmacology

Volumn 18, Issue 1, 2015, Pages

  Watterson, Lucas R ^a   Burrows, Brian T ^a   Hernandez, Raymundo D ^a   Moore, Katherine N ^b   Grabenauer, Megan ^b   Marusich, Julie A ^b   Olive, M Foster ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Abuse liability; Bath salts; ICSS; Psychostimulants; Synthetic cathinones

Indexed keywords

4 METHYL N ETHYLCATHINONE; 4' METHYLMETHCATHINONE; ALPHA PYRROLIDINOPENTIOPHENONE; BATH SALT; CATHINONE; INORGANIC SALT; METHAMPHETAMINE; METHYLENEDIOXYPYROVALERONE; METHYLONE; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG; 1-PHENYL-2-(1-PYRROLIDINYL)-1-PENTANONE; ALKANONE; CENTRAL STIMULANT AGENT; PYRROLIDINE DERIVATIVE; STREET DRUG;

ARTICLE; BRAIN; DRUG DOSE; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SELF STIMULATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STATISTICAL MODEL;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LINEAR MODELS; MALE; METHAMPHETAMINE; MOLECULAR STRUCTURE; PENTANONES; PYRROLIDINES; RATS, SPRAGUE-DAWLEY; SELF STIMULATION; STREET DRUGS;

EID: 84934994075     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyu014     Document Type: Article

References (35)

1. Bauer C, Banks M, Blough B, Negus S (2013) Use of intracranial selfstimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol 168:850-862.
2. Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:192-203.
3. Baumann MH, Partilla JS, Lehner KS (2013) Psychoactive "bath salts": not so soothing. Eur J Pharmacol 698:1-5.
4. Bonano JS, Glennon RA, De Felice LJ, Banks ML, Negus SS (2013) Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology (Berl) 231:199-207.
5. Cardinal RN, Aitken MR (2006) ANOVA for the behavioural sciences researcher. L Erlbaum Association: Mahway, NJ, pp 94-103.
6. Coppola M, Mondola R (2012) 3,4-Methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 208:12-15.
7. Hubner C, Bird M, Rassnick S (1988) The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward. Psychopharmacology 95:49-51.
8. Iversen L, Gibbons S, Treble R, Setola V, Huang X-P, Roth BL (2013) Neurochemical profiles of some novel psychoactive substances. Eur J Pharmacol 700:147-151.
9. Kaizaki A, Tanaka S, Numazawa S (2014) New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron. J Toxicol Sci 39:1-6.
10. Lehner KR, Baumann MH (2013) Psychoactive "bath salts": compounds, mechanisms, and toxicities. Neuropsychopharmacol 38:243-244.
11. Markou A, Koob GF (1992) Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51:111-119.
12. Marusich JA, Antonazzi KR, Wiley JL, Blough BE, Partialla JS, Baumann MH (2014) Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology. In press.
13. Meltzer PC, Butler D, Deschamps JR, Madras BK (2006) 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 49:1420-1432.
14. Prosser JM, Nelson LS (2011) The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8:33-42.
15. Rosenbaum C, Carreiro S, Babu K (2012) Here today, gone tomorrow and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine. J Med Toxicol 8:15-22.
16. Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23-40.
17. Rothman RB, Baumann MH (2006) Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann NY Acad Sci 1074:245-260.
18. Schenk S, Gittings D, Johnstone M, Evangline D (2003) Development, maintenance and temporal pattern of selfadministration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169:21-27.
19. Schenk S, Colussi-Mas J, Do J, Bird J (2012) Profile of MDMA selfadministration from a large cohort of rats: MDMA develops a profile of dependence with extended testing. J Drug Alcohol Res 1:1-6.
20. Sidman, M. (1960). Tactics of scientific research. New York: Basic Books, Inc.
21. Simmler L, Buser T, Donzelli M, Schramm Y, Dieu L-H, Huwyler J, Chaboz S, Hoener M, Liechti M (2013) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168:458-470.
22. Simmler L, Rickli A, Hoener MC, Liechti ME (2014) Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology 79:152-160.
23. Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol 49:499-505.
24. United Nations Office on Drugs and Crime (2013) World Drug Report. Vienna: United Nations.
25. United States Department of Justice Drug Enforcement Administration (2011a) background, data and analysis of synthetic cathinones: mephedrone (4-MMC), methylone (MDMC) and 3,4-methylenedioxypyrovalerone (mdpv). Washington, DC: U.S. Government Printing Office.
26. United States Department of Justice Drug Enforcement Administration (2011b) Chemicals used in "bath salts" Now under federal control and regulation Washington, DC: U.S. Government Printing Office.
27. United States Department of Justice Drug Enforcement Administration (2013a) Federal Register, Vol. 78, No. 71, Friday, April 12, 2013/Rules and regulations.
28. United States Department of Justice Drug Enforcement Administration (2013b) Synthetic cannabinoids and cathinones - DEA request for information.
29. United States Department of Justice NDIC (2011c) Synthetic cathinones (bath salts): an emerging domestic threat. United States of America, One Hundred Twelfth Congress (2012) S. 3187: Food and Drug Administration Safety and Innovation Act.
30. Vlachou S, Markou A (2011) Intracranial self-stimulation. In: Animal models of drug addiction (Olmstead MC, ed), pp 3-56. New York: Springer.
31. Watterson LR, Hood LE, Sewalia K, Tomek SE, Yahn S, Johnson CT, Wegner S, Blough BE, Marusich JA, Olive MF (2012) The reinforcing and rewarding effects of methylone, a synthetic cathinone commonly found in "bath salts." J Addict Res Ther s9:1-8.
32. Watterson LR, Watterson E, Olive MF (2013) Abuse liability of novel "legal high" designer stimulants: evidence from animal models. Behav Pharmacol 24:341-355.
33. Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, Marusich JA, Wegner S, Olive MF (2014) Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 19:165-174.
34. Watterson LR, Olive MF (2014) Synthetic cathinones and their rewarding and reinforcing effects in rodents. Adv Neurosci 2014:1-9.
35. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313:848-854.